Effect of omega-3 on blood pressure and serum lipids in continuous ambulatory peritoneal dialysis patients

Not Applicable

• Conditions: End Stage Renal Disease.; End Stage Renal Disease

• Registration Number: IRCT201501112417N16
• Lead Sponsor: Vice Chancellor for Research, Isfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

inclusion criteria: Clinically stable patients without serious disease; continuous ambulatory peritoneal dialysis (CAPD) for at least 3 months; hypertension stage 1(according to JNC VII) or under treatment. Exclusion criteria: history of steatorrhea; malignancy; thrombocytopenia (PLT<100000/mm3); abnormal coagulation profile; need for anticoagulation therapy; psychosomatic disorders.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Triglyceride. Timepoint: Begining of the study, after 6 weeks. Method of measurement: mg/dL.;Cholesterol. Timepoint: Begining of the study, after 6 weeks. Method of measurement: mg/dL.;High density lipoprotein (HDL). Timepoint: Begining of the study, after 6 weeks. Method of measurement: mg/dL.;Systolic blood pressure. Timepoint: Begining of the study, after 6 weeks. Method of measurement: mmHg.;Diastolic blood pressure. Timepoint: Begining of the study, after 6 weeks. Method of measurement: mmHg.